Geode Capital Management’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $7.42K | Buy |
|
|||||
|
2024
Q1 | $325K | Buy |
|
|||||
|
2023
Q4 | $191K | Buy |
|
|||||
|
2023
Q3 | $158K | Buy |
|
|||||
|
2023
Q2 | $87.2K | Hold |
|
|||||
|
2023
Q1 | $37.8K | Sell |
|
|||||
|
2022
Q4 | $45K | Hold |
|
|||||
|
2022
Q3 | $60K | Hold |
|
|||||
|
2022
Q2 | $151K | Hold |
|
|||||
|
2022
Q1 | $426K | Buy |
|
|||||
|
2021
Q4 | $793K | Buy |
|
|||||
|
2021
Q3 | $337K | Buy |
|